CME Group Announces 10 Firms Trading USD Eris Interest Rate Swap Futures on CME Globex

CHICAGO, Dec. 6, 2018

USD Eris Interest Rate Swap Futures provide a leading alternative to traditional over-the-counter (OTC) interest rate swaps, providing margin offsets with CME Group's suite of interest rate futures products, including Treasury Futures, Eurodollar Futures, Fed Fund Futures, and MAC Swap Futures. 

"We are pleased to offer our customers the ability to trade USD Eris Interest Rate Swap Futures here at CME Group," said Agha Mirza, Global Head of Interest Rate Products at CME Group. "The innovative product design offers our customers another tool for capital-efficient risk management, with unparalleled global distribution to fixed income traders."

"With its industry-leading suite of U.S. dollar interest rate futures, extensive global distribution and functionality-rich CME Globex platform, CME Group is well positioned to take Eris Swap Futures to the next level of market adoption as a capital-efficient alternative to OTC swaps," said Michael Riddle, CEO of Eris Innovations, the owner of the Eris Methodology, the patented product design of Eris Swap Futures.

"As an active participant in Eris Swap Futures markets, BlueCrest welcomes the successful transition of this innovative product on to the CME Group platform," said Michael Platt, CEO and Co-Founder of BlueCrest Capital Management, the global private investment partnership. "The migration to CME Globex further enhances BlueCrest's ability to use Eris Swap Futures to trade swap risk, leveraging the unique advantages offered by the futures market structure."

CME Group holds an exclusive licensing agreement with Eris Exchange to list USD Eris Interest Rate Swap Futures, which have cleared through CME Clearing since 2010. Existing open interest in the contracts was transferred to CME Group on Dec. 3, 2018.

Eris Futures are listed with and subject to the rules and regulations of CBOT. For more information, please visit www.cmegroup.com/swapfutures.